Kai Xiao

7PUBLICATIONS
1CO-AUTHORS
Molecular targetsPredictive and prognostic markersTraditional Chinese medicine and treatmentsNanotoxicology, health and safetyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jan 28, 2026
Leveraging Acquired EGFR-TKI-Resistant Models to Identify MUC16 as a Therapeutic Vulnerability in Lung Adenocarcinoma.

Yinhua Tan, Chunxiu Xiao, Zhifan Wang

|Dec 23, 2022
Nanoparticle-Mediated Delivery of STAT3 Inhibitors in the Treatment of Lung Cancer.

Qiyi Feng, Kai Xiao

|Aug 26, 2022
Nanoparticles-Based Strategies to Improve the Delivery of Therapeutic Small Interfering RNA in Precision Oncology.

Jinxing Huang, Kai Xiao

|Apr 28, 2022
Targeted Drug/Gene/Photodynamic Therapy via a Stimuli-Responsive Dendritic-Polymer-Based Nanococktail for Treatment of EGFR-TKI-Resistant Non-Small-Cell Lung Cancer.

Jinxing Huang, Cheng Zhuang, Jie Chen

|Oct 11, 2021
Prescription of Sageretia hamosa Brongn Relieved Goiter through Promoted Apoptosis of Thyroid Cells via miR-511-3p and PTEN/PI3K/Akt Pathway.

Yang-Lin Deng, Su Chen, Hong-Tu Wang

|Dec 07, 2020
The Effects of Gold Nanoparticles on Leydig Cells and Male Reproductive Function in Mice.

Ying Liu, Xiaojie Li, Shuwen Xiao

Pageof 2

Frequent Collaborators

1 joint publications

Shuwen Xiao